MG
GH icon

Michael Gelband’s Guardant Health GH Stock Holding History

Michael Gelband’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7M Buy
164,518
+11,820
+8% +$1.29M 0.16% 99
2026
Q1 		$14.1M Buy
+152,698
New +$15.3M 0.11% 154
2024
Q3 		– Sell
-440,379
Closed -$12.7M – 1786
2024
Q2 		$12.7M Buy
440,379
+420,093
+2,071% +$9.78M 0.09% 214
2024
Q1 		$419K Buy
+20,286
New +$435K ﹤0.01% 1177
2023
Q4 		– Sell
-257,409
Closed -$7.63M – 1682
2023
Q3 		$7.63M Buy
257,409
+155,384
+152% +$5.46M 0.07% 276
2023
Q2 		$3.65M Sell
102,025
-51,566
-34% -$1.48M 0.03% 566
2023
Q1 		$3.6M Buy
153,591
+139,159
+964% +$3.97M 0.03% 636
2022
Q4 		$393K Buy
14,432
+10,080
+232% +$461K 0.01% 1267
2022
Q3 		$234K Sell
4,352
-9,506
-69% -$488K ﹤0.01% 1594
2022
Q2 		$559K Buy
+13,858
New +$687K 0.01% 1304
2021
Q3 		– Sell
-21,157
Closed -$2.63M – 2309
2021
Q2 		$2.63M Sell
21,157
-36,646
-63% -$4.93M 0.03% 559
2021
Q1 		$8.82M Buy
57,803
+3,616
+7% +$546K 0.13% 145
2020
Q4 		$6.98M Sell
54,187
-23,159
-30% -$2.66M 0.07% 183
2020
Q3 		$8.65M Buy
+77,346
New +$7.08M 0.17% 102
2020
Q2 		– Sell
-4,818
Closed -$335K – 1863
2020
Q1 		$335K Buy
4,818
+1,818
+61% +$140K 0.02% 617
2019
Q4 		$234K Buy
+3,000
New +$216K ﹤0.01% 1268

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Michael Gelband's GH Position: Q2 2026 in Review

Michael Gelband increased its Guardant Health (GH) stake by 7.7% in Q2 2026, buying an estimated $1.29M and bringing the position to 164,518 shares worth $24.7M. The position accounts for 0.16% of the portfolio, ranked #99.

Michael Gelband first reported a position in GH in Q4 2019 and has held it in 16 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Michael Gelband held 164,518 shares of Guardant Health worth $24.7M as of Q2 2026.
  • Michael Gelband bought 11,820 Guardant Health shares in Q2 2026, an estimated $1.29M.
  • Guardant Health made up 0.16% of Michael Gelband's portfolio in Q2 2026, its #99 holding.
  • Michael Gelband first reported a position in Guardant Health in Q4 2019 and has held it in 16 quarters since.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.